Skip to content
The Nexus
DossierENTITY

Gabriel Alizai

Coverage of Gabriel Alizai in the Nexus archive.

Earliest in view: Jun 29 · 19:59 UTCMost recent: Jun 29 · 19:59 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 29 · 19:59 UTCWDIV CLICKONDETROIT
    FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

    The FDA's upcoming panel to review controversial peptide drugs includes health professionals with financial ties to the industry, including clinics and pharmacies promoting unproven peptides. The meeting follows concerns about the safety and regulatory status of substances like BPC-157 and TB-500, which are marketed for wellness purposes but lack scientific validation. Health Secretary Robert F. Kennedy Jr. has publicly supported these peptides.